The Application Value of Dry Fluorescent Luminescence in The Diagnosis and Treatment of HBV Infection

Song-qin LV; Xi-ruo SUN; Shan HUANG; Li-ping XV; Juan ZHANG; Yi-na WANG; Xiao-fei LI; Yong-rui YANG

doi:10.12259/j.issn.2095-610X.S20210812

Volume 42 Issue 8

Aug. 2021

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2021 > 42(8): 65-70

Song-qin LV, Xi-ruo SUN, Shan HUANG, Li-ping XV, Juan ZHANG, Yi-na WANG, Xiao-fei LI, Yong-rui YANG. The Application Value of Dry Fluorescent Luminescence in The Diagnosis and Treatment of HBV Infection[J]. Journal of Kunming Medical University, 2021, 42(8): 65-70. doi: 10.12259/j.issn.2095-610X.S20210812

Citation:

Song-qin LV, Xi-ruo SUN, Shan HUANG, Li-ping XV, Juan ZHANG, Yi-na WANG, Xiao-fei LI, Yong-rui YANG. The Application Value of Dry Fluorescent Luminescence in The Diagnosis and Treatment of HBV Infection[J]. Journal of Kunming Medical University, 2021, 42(8): 65-70. doi: 10.12259/j.issn.2095-610X.S20210812

Citation:

Song-qin LV, Xi-ruo SUN, Shan HUANG, Li-ping XV, Juan ZHANG, Yi-na WANG, Xiao-fei LI, Yong-rui YANG. The Application Value of Dry Fluorescent Luminescence in The Diagnosis and Treatment of HBV Infection[J]. Journal of Kunming Medical University, 2021, 42(8): 65-70. doi: 10.12259/j.issn.2095-610X.S20210812

PDF( 861 KB)

The Application Value of Dry Fluorescent Luminescence in The Diagnosis and Treatment of HBV Infection

doi: 10.12259/j.issn.2095-610X.S20210812

1.
The 3rd People’s Hospital of Kunming/Clinical Center for Infectious Diseases in Yunnan Province，Kunming Yunnan 650041
2.
Shanghai Rongsheng Biology Pharmacy Company，Shanghai 201108，China

Received Date: 2021-06-18
Available Online: 2021-08-03
Publish Date: 2021-08-04

Abstract

Abstract

Objective To analyze and evaluate the application value of dry fluorescent luminescence in the diagnosis and treatment of HBV infection. Methods A total of 397 serum samples were collected from patients attending Liver Diseases Department of the Third People’ s Hospital of Kunming from June 1, 2020 to December 31, 2020. Among these samples, 360 were detected for HBsAg, HBsAb, HBeAg, HBeAb and HBcAb by dry fluorescent luminescence method and ELISA, and 37 HBsAg positive samples in HBeAg seroconversion period detected by electrochemiluminescence method were tested for HBsAg, HBeAg and HBeAb by three methods: dry fluorescent luminescence method, enzyme-linked immunosorbent assay and colloidal gold method. The positive coincidence rate, negative coincidence rate and total coincidence rate of each test item by dry fluorescent luminescence method in diagnosis and treatment of HBV infection were compared and analyzed. Results The S/C value of ELISA was consistent with the trend of S/C value of dry fluorescent luminescence method, showing a certain positive correlation （r = 0.819, 0.913, 0.906, 0.732, 0.842, P < 0.001）. The positive coincidence rate, negative coincidence rate and total coincidence rate of the five items of HBV by the two detection techniques were more than 90%, with high consistency （Kappa = 0.949, 0.944, 0.955, 0.842, 0.949）. The results of 37 serum samples from HBsAg positive HBeAg seroconversion period showed that the coincidence rate between dry fluorescent luminescence method and Roche electrochemiluminescence HBeAb was 100% （37/37）, much higher than that of ELISA 18.92% （7/37） and colloidal gold 5.40% （2/37）. Conclusion Dry fluorescent luminescence method can effectively reflect the serological conversion period of HBeAg. Conventional HBV screening test and enzyme-linked immunosorbent assay have a high consistency. At the same time, it has the advantages of short detection time, no frequent manual operation and simple operation, so it has a good application prospect.
- Dry fluorescent luminescence,
- Hepatitis B virus,
- Accuracy rate

FullText(HTML)

References(15)

References

[1]	Li M,Zu J. The review of differential equation models of HBV infection dynamics[J]. J Virol Methods,2019,266(6):103-113.
[2]	Nasir M,Wu G Y. HEV and HBV Dual Infection:A Review[J]. J Clin Transl Hepatol,2020,8(3):313-321.
[3]	Jia Y,Shu X,Yang X,et al. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis[J]. Stem Cell Res Ther,2020,11(1):277. doi: 10.1186/s13287-020-01787-4
[4]	Kanda T,Goto T,Hirotsu Y,et al. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections:A Review[J]. Int J Mol Sci,2019,20(6):1358. doi: 10.3390/ijms20061358
[5]	陈忠伟,樊怡昕,胡汉宁,等. 慢性乙型肝炎相关原发性肝癌的生物标志物:新的发现和未来之路[J]. 湖北大学学报(自然科学版),2021,43(1):33-40,47.
[6]	Chen Y,Tian Z. HBV-Induced Immune Imbalance in the Development of HCC[J]. Front Immunol,2019,27(10):2048.
[7]	中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015更新版)[J]. 中华肝脏病杂志,2015,23(12):888-905. doi: 10.3760/cma.j.issn.1007-3418.2015.12.002
[8]	Liu Y,Wu C,Chen R,et al. Molecular cloning and phenotypic analysis of drug-resistance mutants with relevant S-region variants of HBV for a patient during 189-month anti-HBV treatment[J]. Antivir Ther,2019,24(4):237-246. doi: 10.3851/IMP3305
[9]	谢青,宁琴,王贵强,等. 乙型肝炎临床治愈策略:抗病毒药物与免疫调节治疗[J]. 中华肝脏病杂志,2020,28(8):644-648. doi: 10.3760/cma.j.cn501113-20200722-00410
[10]	Li H Y,Jia W N,Li X Y,et al. Advances in detection of infectious agents by aptamer-based technologies[J]. Emerg Microbes Infect,2020,9(1):1671-1681. doi: 10.1080/22221751.2020.1792352
[11]	Furuta M,Tanaka H,Shiraishi Y,et al. Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers[J]. Oncotarget,2018,9(38):25075-25088. doi: 10.18632/oncotarget.25308
[12]	云南省2013-2017年农村地区育龄人群HBsAg筛查结果分析[J]. 中华流行病学杂志, 2020, 41（9）: 1522-1526.
[13]	王新梅,臧亮,邓雪莲,等. 化学发光和酶免2种检测系统检测HBsAg情况分析[J]. 中国输血杂志,2020,33(3):222-226.
[14]	钟曼华,陈燕鸿,王小凤,等. HBeAg阳性CHB患者核苷类似物治疗停药后复发情况及其影响因素分析[J]. 山东医药,2021,61(10):60-62. doi: 10.3969/j.issn.1002-266X.2021.10.014
[15]	Ouyang Y,Fu X,Peng S,et al. Plasma miR-146a predicts serological conversion of hepatitis B e-antigen(HBeAg)in chronic hepatitis B patients treated with nucleotide analogs[J]. Ann Transl Med,2019,7(18):449. doi: 10.21037/atm.2019.08.72

Relative Articles(20)

Relative Articles

[1]	Qian AI, Zhirong ZHAO, Yue WU, Haiwen LI, Shenghao LI, Yongrui YANG. Analysis of Antiviral Efficacy and Safety in Patients with Chronic Hepatitis B in Indeterminate Phase. Journal of Kunming Medical University, 2025, 46(1): 51-59. doi: 10.12259/j.issn.2095-610X.S20250107
[2]	Ti WU, Kang HUANG, Zhirong ZHAO, Haiwen LI, Xiaofei LI, Yongrui YANG. The Efficacy and Safety of Different Antiviral Treatment Regimens in Patients with ALT Elevation and Low Viral Load in the Indeterminate Phase of Chronic Hepatitis B. Journal of Kunming Medical University, 2023, 44(1): 97-103. doi: 10.12259/j.issn.2095-610X.S20230117
[3]	Xiaoyan WANG, Ya LI, Chenglu HE, Lin WANG, Zhiqiang MA, Xinrui WAN. Study on Immune Function and Drug Resistance of Tuberculosis Patients Co-infected with HBV，HCV and HIV in Yunnan. Journal of Kunming Medical University, 2023, 44(12): 51-58. doi: 10.12259/j.issn.2095-610X.S20231209
[4]	Dong PU, Tingting YU, Lihua LI, Runwu ZHANG, Kunli WU, Dongling LI. Analysis of Serum High-sensitivity HBV DNA in Patients with Chronic Hepatitis B with Low Viral Load in Kunming Area. Journal of Kunming Medical University, 2023, 44(1): 116-121. doi: 10.12259/j.issn.2095-610X.S20230114
[5]	Xiaojie CHEN, Xingrao WU, Shuhui YU, Zheng LI, Lan ZHANG. Advances on HBV Infection in the Occurrence and Development of Gynecologic Malignancies. Journal of Kunming Medical University, 2022, 43(4): 152-157. doi: 10.12259/j.issn.2095-610X.S20220424
[6]	Zhi-rong ZHAO, Hai-wen LI, Ni-hong LU, Ling SHEN, Xiao-fei LI, Yong-rui YANG. A Clinical Study on the Use of Propofol Tenofovir in the Treatment of Chronic Hepatitis B. Journal of Kunming Medical University, 2021, 42(1): 89-93. doi: 10.12259/j.issn.2095-610X.S20210141
[7]	Fan CAO, Yang-wen LIU, Lei WEI, Nan XIE, Yi-jian YANG, Cheng QIAN, Chun-mang LI, Bi-mang FU, Jiang-pin XU, Rong-ji YAN, Wang ZENG. Correlation between Hepatitis B Virus and Microvascular Invasion in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2021, 42(3): 127-134. doi: 10.12259/j.issn.2095-610X.S20210331
[8]	Pu Dong , Li Xiao Fei , Yu Ting Ting , Wang Hong Ying , Zhang Run Wu , Li Li Hua , Bai Jing , Ding Cai Mei , Li Dong Ling , Yang Yong Rui . . Journal of Kunming Medical University, 2020, 41(06): 149-155.
[9]	Pu Dong , Yu Ting Ting , Wang Hong Ying , Li Li Hua , Zhang Run Wu , Ding Cai Mei , Bai Jing , Li Dong Ling , Li Xiao Fei . . Journal of Kunming Medical University, 2019, 40(11): 131-135.
[10]	Yang Yong Rui , Li Xiao Fei , Liu Jun , Guo Ying Wu , Shen Ling . . Journal of Kunming Medical University, 2018, 39(11): 110-113.
[11]	Li Yong Gang . Vertical Transmission of Hepatitis B Virus in Human Early Embryos. Journal of Kunming Medical University,
[12]	Liu Gui Lan . . Journal of Kunming Medical University,
[13]	Ning Lin . . Journal of Kunming Medical University,
[14]	Lan Qing . . Journal of Kunming Medical University,
[15]	Li Hui . . Journal of Kunming Medical University,
[16]	Zhang Qing . . Journal of Kunming Medical University,
[17]	Su Ying . . Journal of Kunming Medical University,
[18]	Guo Xian Li . . Journal of Kunming Medical University,
[19]	. The Amino Acid Metabolism and the Concentration Change of Homocystenine in Hepatitis B Patients. Journal of Kunming Medical University,
[20]	Li Wu . . Journal of Kunming Medical University,